|
|
Volumn , Issue , 2008, Pages 60-67
|
|
Epigenetic modulation and other options to improve outcome of stem cell transplantation in MDS.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BUSULFAN;
CYCLOPHOSPHAMIDE;
ENZYME INHIBITOR;
HISTONE DEACETYLASE;
DISEASE COURSE;
DONOR;
DRUG ANTAGONISM;
DRUG COMBINATION;
GENETIC EPIGENESIS;
GENETICS;
HUMAN;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
MYELODYSPLASTIC SYNDROME;
MYELOID LEUKEMIA;
RECURRENT DISEASE;
REVIEW;
RISK FACTOR;
SIBLING;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
WHOLE BODY RADIATION;
BUSULFAN;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DISEASE PROGRESSION;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
EPIGENESIS, GENETIC;
HISTONE DEACETYLASES;
HUMANS;
LEUKEMIA, MYELOID;
MYELODYSPLASTIC SYNDROMES;
RECURRENCE;
RISK FACTORS;
SIBLINGS;
STEM CELL TRANSPLANTATION;
TISSUE DONORS;
TREATMENT OUTCOME;
WHOLE-BODY IRRADIATION;
|
|
EID: 67651153105
PISSN: 15204391
EISSN: None
Source Type: Journal
DOI: 10.1182/asheducation-2008.1.60 Document Type: Review |
|
Times cited : (10)
|
|
References (52)
|
